Consensus RadNet, Inc.

Stocks

RDNT

US7504911022

Healthcare Facilities & Services

Market Closed - Nasdaq 23:00:00 27/10/2026 +03			5-day change	1st Jan Change
73.54 ^USD	+4.98%		+5.59%	+3.07%

10-27	ONRAD, Inc., RadNet, Inc. - M&A Call
10-27	RadNet to Acquire ONRAD in Cash and Stock Deal	MT

Evolution of the Average Target: RadNet, Inc.

Evolution of the Target Price: RadNet, Inc.

Changes in Analyst Recommendations: RadNet, Inc.

508bd8.pQ6mGSUSgxqwFjNJsaufdCm5GW3VkBVsiq0Ugwl9H3Y.kVfPSGh87HeCU2sc5djAIE_cVAuF91xBs-lVsTgqRzX2ONJPEGHqItRneg~34b7b9b8aa9b2ed0f63f0002bbd30bf3

Analysts' recommendations: RadNet, Inc.

08-11	B. Riley Adjusts Price Target on RadNet to $96 From $83, Maintains Buy Rating	MT
08-11	Truist Adjusts Price Target on RadNet to $94 From $90, Maintains Buy Rating	MT
05-01	B. Riley Adjusts Price Target on RadNet to $83 From $87, Maintains Buy Rating	MT
12-01	B. Riley Raises Price Target on RadNet to $87 From $71, Keeps Buy Rating	MT
11-12	Truist Raises Price Target on RadNet to $90 From $81, Keeps Buy Rating	MT
03/09/25	Truist Raises Price Target on RadNet to $81 From $74, Keeps Buy Rating	MT
12/08/25	B. Riley Adjusts Price Target on RadNet to $71 From $69, Maintains Buy Rating	MT
13/06/25	B. Riley Initiates RadNet at Buy With $69 Price Target	MT
17/04/25	RadNet's iCAD Deal to Expand its Digital Health Services and Geographic Presence, Truist Says	MT
11/04/25	Truist Securities Cuts Price Target on RadNet to $74 From $88, Keeps Buy Rating	MT
22/01/25	Truist Securities Cuts Price Target on RadNet to $88 From $94, Keeps Buy Rating	MT
29/11/24	Truist Raises Price Target on RadNet to $94 From $80, Keeps Buy Rating	MT
11/11/24	Top Midday Gainers	MT
04/10/24	Sidoti Adjusts RadNet Price Target to $88 From $72, Maintains Buy Rating	MT
23/09/24	Truist Raises Price Target on RadNet to $80 From $70, Maintains Buy Rating	MT
06/09/24	Barclays Upgrades RadNet to Overweight From Equal Weight	MT
15/07/24	Truist Securities Adjusts Price Target on RadNet to $70 From $63, Maintains Buy Rating	MT
11/07/24	Jefferies Adjusts Price Target on RadNet to $75 From $61, Maintains Buy Rating	MT
15/05/24	Truist Securities Adjusts Price Target on RadNet to $63 From $55, Maintains Buy Rating	MT
28/03/24	Truist Securities Raises Price Target on RadNet to $55 From $51, Maintains Buy Rating	MT
06/03/24	Barclays Starts Coverage on RadNet With Equalweight Rating, $48 Price Target	MT
04/03/24	Truist Securities Adjusts RadNet Price Target to $51 From $42, Maintains Buy Rating	MT
08/12/23	Truist Adjusts RadNet's Price Target to $42 From $40, Maintains Buy Rating	MT
31/08/23	Truist Securities Starts RadNet at Buy With $40 Price Target	MT
26/06/23	Raymond James Raises Price Target on RadNet to $40 From $35, Keeps Outperform Rating	MT

More recommendations

Medical & Diagnostic Laboratories

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	RADNET, INC.					+35.08%
	CVS HEALTH CORPORATION					+24.8%
	HCA HEALTHCARE, INC.					-0.74%
	NATERA, INC.					+1.6%
	FRESENIUS SE & CO. KGAA					+20.5%
	LABCORP HOLDINGS INC.					+4.62%
	QUEST DIAGNOSTICS INCORPORATED					+4.85%
	TENET HEALTHCARE CORPORATION					+6.49%
	DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY					+18.21%
	IHH HEALTHCARE					+31.07%
	Average					+14.65%
	Weighted average by Cap.					+11.87%